TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort.

An-Chi Tien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.